» Articles » PMID: 11003609

Myosin Light Chain Kinase Transference Induces Myosin Light Chain Activation and Endothelial Hyperpermeability

Overview
Specialties Cell Biology
Physiology
Date 2000 Sep 26
PMID 11003609
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The actomyosin complex is the major cytoskeletal component that controls cell contraction. In this study, we investigated the effects of actomyosin interaction on endothelial barrier function and gap formation. Activated myosin light chain kinase (MLCK) protein was transferred into coronary venular endothelial cell (CVEC) monolayers. Uptake of the activated protein resulted in a significant shift in myosin light chain (MLC) from an unphosphorylated to a diphosphorylated form. In addition, MLCK induced a hyperpermeability response of the monolayer as measured by albumin transendothelial flux. Microscopic examination of MLCK-treated CVECs revealed widespread gap formation in the monolayer, loss of peripheral beta-catenin, and increases in actin stress fibers. Inhibition of all of the above responses by a specific MLCK inhibitor suggests they are the direct result of exogenously added MLCK. These data suggest that activation of MLCK in CVECs causes phosphorylation of MLC and contraction of CVECs, resulting in gap formation and concomitant increases in permeability. This study uses a novel technique to measure the effects of an activated kinase on both its substrate and cellular morphology and function through direct transference into endothelial cells.

Citing Articles

Trifluoperazine regulates blood-brain barrier permeability via the MLCK/p-MLC pathway to promote ischemic stroke recovery.

Zhang W, Chen S, Ma B, Ding Y, Liu X, He C iScience. 2024; 27(3):109156.

PMID: 38439960 PMC: 10910233. DOI: 10.1016/j.isci.2024.109156.


Inhibition of UTX/KDM6A improves recovery of spinal cord injury by attenuating BSCB permeability and macrophage infiltration through the MLCK/p-MLC pathway.

Xie Y, Luo Z, Peng W, Liu Y, Yuan F, Xu J J Neuroinflammation. 2023; 20(1):259.

PMID: 37951955 PMC: 10638785. DOI: 10.1186/s12974-023-02936-1.


Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner.

Baoyinna B, Miao J, Oliver P, Ye Q, Shaheen N, Kalin T Biomedicines. 2023; 11(9).

PMID: 37760892 PMC: 10525432. DOI: 10.3390/biomedicines11092451.


Edema and lymphatic clearance: molecular mechanisms and ongoing challenges.

Breslin J Clin Sci (Lond). 2023; 137(18):1451-1476.

PMID: 37732545 PMC: 11025659. DOI: 10.1042/CS20220314.


Modulating the Blood-Brain Barrier: A Comprehensive Review.

Whelan R, Hargaden G, Knox A Pharmaceutics. 2021; 13(11).

PMID: 34834395 PMC: 8618722. DOI: 10.3390/pharmaceutics13111980.